POC Pharma is a SaaS Company supporting pharma stakeholders to digitally manage their interactions, and grow faster and cheaper.
POC Pharma has raised $10.3M in total funding. The most recent round was Series A. The last funding was announced in April 2022.
POC Pharma's investors include 500 Global, FJ Labs, Alven, Picus Capital, Goat Capital.
POC Pharma is headquartered in Hong Kong, Hong Kong.
POC Pharma is a SaaS Company supporting pharma stakeholders to digitally manage their interactions, and grow faster and cheaper.
POC Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"POC Pharma — Funding & Investors." VCBacked, April 20, 2022, https://www.vcbacked.co/company/poc-pharma. Accessed August 15, 2026.
VCBacked. (2022). POC Pharma — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/poc-pharma
{{cite web |title=POC Pharma — Funding & Investors |url=https://www.vcbacked.co/company/poc-pharma |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated